(Q37361239)

19 August 2017

1 reference

title

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials (English)

1 reference

19 August 2017

0 references

0 references

1 reference

1 reference

4

Matthew E Falagas

1 reference

19 August 2017

Harissios Vliagoftis

1

1 reference

19 August 2017

Vasilios D Kouranos

series ordinal

2

1 reference

19 August 2017

Gregoria I Betsi

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

1 December 2008

1 reference

Annals of Allergy, Asthma & Immunology

19 August 2017

1 reference

19 August 2017

101

1 reference

19 August 2017

6

1 reference

19 August 2017

570-579

1 reference

The global burden of asthma

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics, immunomodulation, and health benefits

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Bacillus clausii effects in children with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Treatment of perennial allergic rhinitis with lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Laser acupuncture and probiotics in school age children with asthma: a randomized, placebo-controlled pilot study of therapy guided by principles of Traditional Chinese Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Immune and clinical impact of Lactobacillus acidophilus on asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

GINA guidelines on asthma and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics for the treatment of women with bacterial vaginosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotics in severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

The intestinal microflora in allergic Estonian and Swedish 2-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Does the microbiota regulate immune responses outside the gut?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

The role of the intestinal microbiota in the development of atopic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960219-0

7 January 2021

10.1016/S1081-1206(10)60219-0

Identifiers

DOI

1 reference

19 August 2017

1 reference